Last updated: January 27, 2025
Sponsor: King Chulalongkorn Memorial Hospital
Overall Status: Active - Recruiting
Phase
3
Condition
Low Blood Sodium (Hyponatremia)
Treatment
Ringer's Lactate Crystalloid Solutions
Normal saline
Clinical Study ID
NCT06030609
CUKT-FLUID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
A kidney transplant recipient who receives transplant at King Chulalongkorn MemorialHospital.
Age >=18 years
Both deceased donor and living donor kidney transplantation will be included
Exclusion
Exclusion Criteria:
multiorgan transplantation
Known allergy to RLS or NSS
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Ringer's Lactate Crystalloid Solutions
Phase: 3
Study Start date:
September 01, 2024
Estimated Completion Date:
March 31, 2026
Connect with a study center
Division of Nephrology, Faculty of Medicine, King Chulalongkorn Memorial Hospital
Bangkok, 10330
ThailandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.